| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.2 | 0.009 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |